{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T23:03:56Z","timestamp":1740179036422,"version":"3.37.3"},"reference-count":13,"publisher":"Springer Publishing Company","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Doct Nurs Pract"],"published-print":{"date-parts":[[2020,7,1]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Alabama has the highest prescription rate in the country. The national incidence of overdose deaths from prescription opioids exceeds the combined death rates from heroin and cocaine overdose. Monitoring prescription access should be an essential activity among providers and can be used to protect patient health and well-being. Prescription drug monitoring programs (PDMPs) are tools that assist in diminishing opioid therapy risks such as diversion, abuse, overdose, and death.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>The purpose of the study was to examine the effects of an educational intervention on opioid prescriptive rates, frequency of self-auditing and days of opioid supply among healthcare providers. The anticipated goal of the project was that rates and days of supply for opioid prescriptions would decrease.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>A pretest\u2013posttest design was used to assess a sample of 21 DEA licensed providers who attended a PDMP presentation and conducted a self-audit using the PDMP.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Analysis showed that 81% of the participants had never conducted a self-audit prior to the intervention. Self-report data indicated that 85.7% of the providers planned to increase their self-auditing use postintervention and 14.3% planned to make no changes to their current use of the PDMP. Among those who prescribed opioids, the range of monthly prescriptions written was 3\u2013142 preintervention (<jats:italic>M<\/jats:italic> = 32.28, <jats:italic>SD<\/jats:italic> = 41.04) and 3\u2013149 postintervention (<jats:italic>M<\/jats:italic> = 32.26, <jats:italic>SD<\/jats:italic> = 43.32). Analysis also found the days of opioid supply prescribed were also high. In both cases, these numbers were correlated to patient census.<\/jats:p><\/jats:sec><jats:sec><jats:title>Implications for Nursing<\/jats:title><jats:p>The PDMP is an effective surveillance tool that provides aggregate data to state public health officials. For a PDMP to be effective, it must be used by prescribing providers. While the anticipated goal for this study was not achieved, the PDMP is an effective surveillance tool for monitoring the controlled substance prescription histories of patients. Using the PDMP before prescribing can aid providers in distinguishing those who legitimately have a need from those who may be seeking to misuse the medications. Additionally, use of a PDMP can provide aggregate data to state public health officials so that education programs, for practitioners and patients, can be developed.<\/jats:p><\/jats:sec>","DOI":"10.1891\/jdnp-d-19-00064","type":"journal-article","created":{"date-parts":[[2020,7,3]],"date-time":"2020-07-03T00:02:27Z","timestamp":1593734547000},"page":"142-147","source":"Crossref","is-referenced-by-count":0,"title":["Provider Prescription Drug Monitoring Program Utilization and Self-Auditing\u2014A Pilot Study"],"prefix":"10.1891","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0062-7693","authenticated-orcid":false,"given":"Whitnee C.","family":"Brown","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelli","family":"Whitted","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"793","published-online":{"date-parts":[[2020,7,2]]},"reference":[{"key":"2020081712251665000_13.2.142.1","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2015.1673"},{"key":"2020081712251665000_13.2.142.2","unstructured":"Centers for Disease Control and Prevention. (2017a). Opioid overdose . Retrieved from https:\/\/www.cdc.gov\/drugoverdose\/prescribing\/patients.html"},{"key":"2020081712251665000_13.2.142.3","unstructured":"Centers for Disease Control and Prevention. (2017b). Prescription opioids . Retrieved from https:\/\/www.cdc.gov\/drugoverdose\/opioids\/prescribed.html"},{"key":"2020081712251665000_13.2.142.4","unstructured":"Centers for Disease Control and Prevention. (2017c). U.S. prescribing rate maps . Retrieved from https:\/\/www.cdc.gov\/drugoverdose\/maps\/rxrate-maps.html"},{"key":"2020081712251665000_13.2.142.5","unstructured":"Centers for Disease Control and Prevention. (2019). Prescribing practices: Changes in opioid prescribing practices . Retrieved from https:\/\/www.cdc.gov\/drugoverdose\/data\/prescribing\/prescribing-practices.html"},{"key":"2020081712251665000_13.2.142.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.nurpra.2018.04.011"},{"key":"2020081712251665000_13.2.142.7","doi-asserted-by":"publisher","DOI":"10.5811\/westjem.2014.10.24197"},{"key":"2020081712251665000_13.2.142.8","unstructured":"Mattson, C. L. , Schieber, L. , Scholl, L. , Rudd, R. A. , Seth, P. , & Xu, L. , \u2026 Paulozzi, L. (2017). Annual surveillance report of drug-related risk and outcomes . Retrieved from https:\/\/www.cdc.gov\/drugoverdose\/pdf\/pubs\/2019-cdc-drug-surveillance-report.pdf"},{"key":"2020081712251665000_13.2.142.9","unstructured":"National Institute of Health. (2018). Fentanyl and other synthetic opioids drug overdose deaths . Retrieved from https:\/\/www.drugabuse.gov\/related-topics\/trends-statistics\/infographics\/fentanyl-other-synthetic-opioids-drug-overdose-deaths"},{"key":"2020081712251665000_13.2.142.10","doi-asserted-by":"publisher","DOI":"10.1377\/hlthaff.2015.1496"},{"key":"2020081712251665000_13.2.142.11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0131080"},{"key":"2020081712251665000_13.2.142.12","unstructured":"U.S. Department of Health and Human Services. (2016). The opioid epidemic: By the numbers . Retrieved from https:\/\/www.hhs.gov\/opioids\/about-the-epidemic\/index.html"},{"key":"2020081712251665000_13.2.142.13","doi-asserted-by":"publisher","DOI":"10.1186\/s12245-017-0140-0"}],"container-title":["Journal of Doctoral Nursing Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1891\/JDNP-D-19-00064","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,17]],"date-time":"2020-08-17T19:26:39Z","timestamp":1597692399000},"score":1,"resource":{"primary":{"URL":"http:\/\/connect.springerpub.com\/lookup\/doi\/10.1891\/JDNP-D-19-00064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,1]]},"references-count":13,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2020,8,17]]},"published-print":{"date-parts":[[2020,7,1]]}},"alternative-id":["10.1891\/JDNP-D-19-00064"],"URL":"https:\/\/doi.org\/10.1891\/jdnp-d-19-00064","relation":{},"ISSN":["2380-9418","2380-9426"],"issn-type":[{"type":"print","value":"2380-9418"},{"type":"electronic","value":"2380-9426"}],"subject":[],"published":{"date-parts":[[2020,7,1]]}}}